The FSR Clinical Studies Network (FSR-CSN) brings together an international consortium of world-renowned medical institutes and researchers for unprecedented collaboration in studies and drug trials toward the treatment of sarcoidosis. The goals of the network are to:
- collaborate for studies,
- test the efficacies of treatment approaches,
- measure the impact of re-purposed drug treatments,
- and rapidly screen new promising compounds that emerge from biomedical research, significantly decreasing the time and amount of money needed to develop them.
FSR-CSN provides a forum to address a range of important but unanswered questions in sarcoidosis, facilitates a move towards broader consensus about clinical endpoints, and enables pharmaceutical industry entrance into the sarcoidosis space with less perceived risk. As an active, working entity, the Network provides a valuable resource for industry, academia, and individual researchers.
The FSR Clinical Studies Network (FSR-CSN) is led by a Steering Committee composed of the Principal Investigators from each participating institution. FSR-CSN is composed of 8 sites, two international and 6 U.S.-based, and FSR intends to expand the size of the CSN as funding allows.
The FSR- CSN currently is conducting two internal studies and several industry-initiated. All results will be published in professional and/or other publications and reports.
|Site||Location||Primary Investigator (Awardee)|
|Albany Medical College||Albany, NY||Judson, Marc|
|Hôpital Avicenne||Bobigny, France||Valeyre, Dominique|
|Cleveland Clinic||Cleveland, OH||Culver, Daniel|
|Johns Hopkins Medicine||Baltimore, MD||Chen, Edward|
|National Jewish Health||Denver, CO||Hamzeh, Nabeel|
|St. Antonius Hospital||Nieuwegein, Netherlands||Grutters, Jan|
|University of Cincinnati||Cincinnati, OH||Baughman, Robert|
|University of Illinois Hospital & Health Sciences System||Chicago, IL||Sweiss, Nadera|
|ILD Care Foundation; WASOG President||(not a site)||Drent, Marjolein: CSN Steering Committee Chair|